Table 5. Univariate validation in GSE73581 cohort.

	HR	95% CI	P-value
OS
miR-1183	1.01	0.78–1.33	0.921
miR-126-3p	1.13	0.96–1.33	0.135
miR-198	0.95	0.73–1.25	0.720
miR-23a-3p	1.10	0.92–1.33	0.289
miR-23a-5p	1.34	0.93–1.93	0.121
miR-27a-3p	1.25	0.98–1.59	0.073
miR-451a	1.08	0.96–1.21	0.191
miR-483-5p	1.11	0.91–1.36	0.302
miR-665	1.02	0.68–1.53	0.914
TTP
miR-125a-3p	1.05	0.91–1.22	0.478
miR-126-3p	1.01	0.90–1.14	0.832
miR-139-3p	1.41	1.05–1.90	0.022
miR-23a-3p	0.98	0.86–1.12	0.799
miR-23a-5p	1.58	1.18–2.12	0.002
miR-27a-3p	1.07	0.90–1.27	0.466
miR-665	1.26	0.93–1.71	0.134

OS = overall survival, HR = hazard ratio, CI = confidence interval, TTP = time to progression. Significant p-values are marked in bold.